Vault-13

Foresite Capital Management VI LLC

WEST HOLLYWOOD, CA · CIK 2013341 · 13F filing filed 2026-02-17

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$330.8m reported value +27.8% vs Q3 2025
12positions
94.9%in top 10
3 new 2 added 1 reduced 3 sold out vs Q3 2025

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 2,221,474 $92.2m27.88% 27.88% UnchangedShares held: Q1 2025 2.2m, Q2 2025 2.2m, Q3 2025 2.2m, Q4 2025 2.2m
2 RAPT THERAPEUTICS INC COM NEW RAPT RAPT 1,562,500 $52.9m16.00% 16.00% UnchangedShares held: Q1 2025 0, Q2 2025 1.6m, Q3 2025 1.6m, Q4 2025 1.6m
3 ALUMIS INC COM ALMS ALMS 4,247,670 $41.5m12.53% 12.53% UnchangedShares held: Q1 2025 4.2m, Q2 2025 4.2m, Q3 2025 4.2m, Q4 2025 4.2m
4 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,364,019 $34.1m10.31% 10.31% AddedShares held: Q1 2025 1.3m, Q2 2025 1.3m, Q3 2025 1.3m, Q4 2025 1.4m +50.0k +50,000 3.8%
5 VERASTEM INC COM NEW VSTM VSTM 3,135,120 $24.2m7.32% 7.32% AddedShares held: Q1 2025 0, Q2 2025 1.3m, Q3 2025 2.6m, Q4 2025 3.1m +520.0k +520,000 19.9%
6 DENALI THERAPEUTICS INC COM DNLI DNLI 1,000,000 $16.5m4.99% 4.99% UnchangedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 1.0m, Q4 2025 1.0m
7 NATERA INC COM NTRA NTRA 67,356 $15.4m4.66% 4.66% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 67.4k
8 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 530,000 $14.4m4.36% 4.36% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 530.0k
9 KYMERA THERAPEUTICS INC COM KYMR KYMR 146,332 $11.4m3.44% 3.44% UnchangedShares held: Q1 2025 146.3k, Q2 2025 146.3k, Q3 2025 146.3k, Q4 2025 146.3k
10 ATAI LIFE SCIENCES NV SHS ATAI ATAI 2,750,000 $11.2m3.40% 3.40% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 2.8m
11 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 1,381,233 $10.6m3.21% 3.21% ReducedShares held: Q1 2025 1.6m, Q2 2025 1.7m, Q3 2025 1.7m, Q4 2025 1.4m -350.0k -350,000 -20.2%
12 HINGE HEALTH INC CL A HNGE HNGE 135,000 $6.3m1.90% 1.90% UnchangedShares held: Q1 2025 0, Q2 2025 135.0k, Q3 2025 135.0k, Q4 2025 135.0k

Sold out since Q3 2025

SecurityTickerShares held beforeValue then
AKERO THERAPEUTICS INC AKRO AKRO 244,900 $11.6m244.9k shares
AVIDITY BIOSCIENCES INC RNA RNA 40,000 $1.7m40.0k shares
CASI PHARMACEUTICALS INC CASIF CASIF 979,956 $1.6m980.0k shares

Trades reported as a company insider in Q4 2025

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2025-11-21 ALUMIS INC 10% owner · See Footnote ALMS Bought 72,212 $532.9k72.2k shares +3%
2025-11-19 ALUMIS INC 10% owner · See Footnote ALMS Bought 190,500 $1.2m190.5k shares +8%
2025-11-18 ALUMIS INC 10% owner · See Footnote ALMS Bought 117,374 $726.5k117.4k shares +5%
2025-11-17 ALUMIS INC 10% owner · See Footnote ALMS Bought 200,000 $1.1m200.0k shares +10%